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Summary (150 words) 25
High throughput single-cell RNA sequencing (sc-RNAseq) has become a frequently 26 used tool to assess immune cell function and heterogeneity. Recently, the combined 27 measurement of RNA and protein expression by sequencing was developed, which is 28 commonly known as CITE-Seq. Acquisition of protein expression data along with 29 transcriptome data resolves some of the limitations inherent to only assessing 30 transcript, but also nearly doubles the sequencing read depth required per single cell. 31
Furthermore, there is still a paucity of analysis tools to visualize combined transcript-32 protein datasets. 33
Here, we describe a novel targeted transcriptomics approach that combines analysis 34 of over 400 genes with simultaneous measurement of over 40 proteins on more than 35
Introduction 42
While pioneering work almost 20 years ago illustrated the ability to study the 43 transcriptome at the single-cell level (Chiang and Melton, 2003; Phillips and Eberwine, 44 1996) , recent advances in microfluidics and reagents allow the high-throughput 45 analysis of transcripts of 10 4 single cells in one experiment (Jaitin et al., 2014; Klein et 46 al., 2015; Macosko et al., 2015) . Although several methods have been developed for 47 this purpose, currently the most widely adopted platform is a droplet-based 48 microfluidic system commercialized by 10x Genomics (Zheng et al., 2017) . 49
Though analysis of transcript expression on the single cell level is a powerful tool to 50 characterize the relationship and functional properties of cells, it is imperative to 51 consider the relationship between transcript and protein when trying to extrapolate 52 biology. Typically, transcripts are expressed at a much lower level than proteins -for 53 example, murine liver cells have a median copy number of 43,100 protein molecules 54 but only 3.7 RNA molecules per gene (Azimifar et al., 2014) . Similarly, the dynamic 55 range of expression is much greater for proteins with copy numbers spanning about 6-56
The parallel measurement of transcript and protein phenotype by sequencing has been 65 recently reported as cellular indexing of transcriptomes and epitopes (CITE-seq) 66 (Stoeckius et al., 2017) or RNA expression and protein sequencing (REAP-seq) 67 (Peterson et al., 2017) . These technologies leverage existing sc-RNAseq platforms that 68 use an unbiased whole transcriptome (WTA) detection approach capturing cellular 69 mRNA via its poly-A tail, and utilize oligonucleotide-labelled antibodies (carrying unique 70 barcodes and also a poly-A tail) to interrogate surface protein abundance. Typically, 71 current droplet-based WTA approaches result in the detection of ~1000 unique 72 transcripts per single cell for the transcriptome (with a substantial fraction of these 73 transcripts encoding ribosomal proteins), while antibody panels of up to 80 targets 74 have been reported (Peterson et al., 2017) . 75
Though proof-of-principle for this technology has been established, it remains unclear 76 how the sequencing-based antibody detection compares to established flow 77 cytometry-based assays in different experimental settings with regards to capturing the 78 dynamic range of protein expression and identifying low abundance protein 79 expression. In addition, the combined WTA plus protein approach can quickly become 80 resource intensive. Finally, droplet-based WTA pipelines may still miss specific 81 transcripts of interest if they are below the limit of detection, with current high 82 throughput chemistries capturing an estimated 10% of the total cellular mRNA (Zheng 83 et al., 2017) . 84
Here, we report using a high throughput (>10 4 single cells) targeted transcriptomic 85 approach employing nanowells to capture single cells (Rhapsody platform, 86 commercialized by BD Biosciences) (Fan et al., 2015) in combination with oligonucleotide-barcoded antibodies (termed AbSeq). Specifically, we simultaneously 88 interrogated over 400 immune-related genes and 41 surface proteins that are 89 commonly used for immunophenotyping. We found that this targeted approach was 90 efficient at detecting low-abundance transcripts while only requiring about 1/10 of the 91 sequencing read depth needed for WTA, indicating that targeted transcriptomics is a 92 sensitive and cost-efficient alternative when the focus is on interrogating defined 93 transcripts. Of note, this approach clearly separated different memory T cell subsets as 94 well as regulatory T cells (Tregs) solely based on transcript information, which is often 95 difficult due to the low amount of RNA recovered from T lymphocytes (Zheng et al., 96 2017 ). Furthermore, we used 30-parameter fluorescent-based flow cytometry to 97 measure the same proteins targets as in the multi-omic assay. Our data indicate that 98 the validation of oligonucleotide-barcoded antibody panels is necessary for meaningful 99 interpretation of the multi-omic data. 100
To demonstrate the sensitivity and robustness of the system we analyzed T and NK 101 cells before and after one hour of stimulation, revealing an unexpected disconnect in 102 transcript and surface expression levels of the commonly used early activation marker 103 CD69. Analysis of chemokine expression showed distinct phenotypes within the CD8 + 104 T cell population as early as 60 minutes after stimulation, suggesting significant 105 heterogeneity within this compartment. 106
Finally, to visualize protein and transcriptome data in an intuitive single plot, we 107 adapted One-SENSE, which was originally developed for visualization of mass 108 cytometry data (Cheng et al., 2016) . This adaptation allows for effective visualization 109 and identification of cellular phenotypes that differ either by transcript or by protein.
Results 116
Comparison of oligonucleotide-labelled antibody probes to high-dimensional flow 117 cytometry 118
For our reference data set we obtained peripheral blood mononuclear cells (PBMCs) 119 from three healthy control subjects carrying the HLA-A*02:01 allele, which allowed 120 isolation of EBV-specific CD8 + T cells using an EBV-Tetramer reagent (Dunne et al., 121 2002) . To ensure sufficient cell numbers of these rare, antigen-specific T cells, we 122 enriched tetramer-positive T cells by fluorescence-activated cell sorting (FACS). In 123 parallel, we sorted CD45 + live leukocytes from PBMCs ( Figure 1A ). Moreover, to 124 minimize batch effects during subsequent staining with 41 oligo-nucleotide labelled 125 myeloid compartment ( Figure 1C ) as well as the lymphoid compartment ( Figure 1D ). All 139 populations were present at comparable frequencies in the two different data sets 140 ( Figure 1E and Figure 1F ), with myeloid cells showing slightly lower abundance due to 141 the sorting procedure required to enrich EBV-Tetramer + cells as well as CD45 + live 142 cells. Of note, even low-abundance cell populations such as CD1c + conventional 143 dendritic cells (cDCs) and crosspresenting CD141 + cDCs were clearly identified by their 144 surface protein phenotype. Furthermore, the oligonucleotide-labelled antibodies 145 allowed to discriminate the CD45 splice variants CD45RO and CD45RA, which cannot 146 be distinguished by 3' transcriptomic analysis alone. 147
However, for the anti-TCRgd reagent we used, discordant patterns were observed 148 when comparing the expression within CD3 + T cells to conventional flow cytometry 149 (Supplementary Figure 1A) . This was not immediately evident when visualizing the data 150 on a heatmap (Supplementary Figure 1B) , emphasizing the need for careful reagent 151 validation for sequencing-based protein measurements. Thus, we did not analyze gd T 152 cells separately for the rest of our study. Furthermore, the CCR7 reagent delivered sub-153 optimal but usable resolution (data not shown). Figure 2A and 2B). For visualization, we used 163 uniform manifold approximation and projection (UMAP), a dimensionality reduction 164 approach that has recently been adopted for single-cell data (Becht et al., 2018; 165 McInnes et al., 2018). Overall, the targeted transcriptomic approach utilizing 490 genes 166 revealed similar or even improved resolution of known immune subsets in the 167 peripheral blood. In particular, CD4 + T cells and CD8 + T cells separated well, and we 168 observed regulatory T cells (Tregs) expressing FOXP3 and CTLA4 as a separate cluster 169 ( Figure 2B ). For verification of this Treg cluster, we utilized the corresponding protein 170 signature, which showed high expression of CD25, and low expression of CD127 171 ( Figure 2C ). Next, we compared the gene expression for four phenotypically similar 172 clusters in the WTA and the targeted transcriptomics data set, showing very similar 173 patterns for the top differentially expressed genes (Suppl. Figure 2B ). To obtain a 174 relative measure of detection efficiency, we calculated the average number of 175 transcripts per cell both for the targeted transcriptomics as well as the WTA data set 176 from the same donor. Around 75% of the assayed genes showed equal or slightly 177 superior detection efficiencies ( Figure 2D ), suggesting that targeted transcriptomics 178 can deliver valuable information at relatively low sequencing cost (i.e. approximately 179 2500 reads/cell). 180
Finally, to directly assess the effect of different read-depths on resolution of protein 181 and transcript signals, we analyzed a different donor to a total of approximately 27,000 182 reads/cell (approximately 18,000 reads/cell for the antibody library, 9,000 reads/cell for 183 the transcript library) and subsampled the number of reads used during processing of the raw data to 20% (approximately 4000 reads/cell for antibody library, 2000 185 reads/cell for transcript library) and 10%. Visualization of the resulting clusters on a 186 UMAP plot as well as the top-differentially expressed genes on a heatmap revealed no 187 major differences between using 100% or 20% of the reads (Supplementary Figure  188 2C). For the protein signal, the same was observed, while using only 10% of the reads 189 resulted in noticeable loss of signal intensities (Supplementary Figure 2D ). Overall, we 
Multi-omic analysis identifies canonical memory T cell populations and allows the study 195 of rare-antigen specific CD8 + T cells 196
To test the value of multi-omic single cell analysis on a specific subset of the immune 197 compartment, we performed an in-depth analysis of the CD8 + T cell compartment. 198
First, we visualized protein and RNA data collected from total CD45 + live cells from 199
PBMCs from three patents on separate UMAP plots ( Fig 1A) . We found that cells from 200 different donors comingled and separated by cell type rather than by donor, 201
suggesting that batch effect across donors was minimal ( Figure 3A ). Of note, protein 202 information overlayed on the transcript-generated UMAP plot allowed accurate 203 identification of all main immune clusters ( Figure 3B ), which is not necessarily the case 204 when using transcript information for the corresponding lineage markers. This is 205 exemplified by biaxial plots showing protein signal on the y-axis and transcript signal 206 on the x-axis ( Figure 3C ): While for CD8A, transcript and protein are co-expressed in 207 most cells, only half of the CD4-protein + (throughout the manuscript abbreviated as 208 CD4-P) cells contained detectable CD4-transcript. In turn, there were other molecules 209 of interest where the inverse was observed: CD69-RNA (plotted on the x-axis) was 210 detected across a large number of T cells, but as expected only few T cells in the 211 peripheral blood express CD69 protein (CD69-P, plotted on y-axis) on their surface. 212
For CD27, we observed a higher correlation between transcript and protein ( Figure 3C ). 213
Overall, these observations emphasize the importance of parallel measurement of 214 protein and transcript to faithfully study T cell biology. 215
Next, we continued our analysis of CD3 + CD4 -CD8 + T cells as defined by surface protein To visualize the correspondence between transcript and protein expression in the 230 multi-omic data set, we adopted One-SENSE, which has originally been developed for 231 biologically meaningful visualization of mass cytometry data (Cheng et al., 2016) . For 232 this, we mapped cells separately by proteins and transcripts each on to a single UMAP 233 dimension, similar to a recently published 1D t-stochastic neighbor embedding (t-SNE) 234
representation for sc-RNA sequencing data (Linderman et al., 2019) . The combined 235 plot shows the overall distribution of protein expression profiles in the x-axis and the 236 top-differentially expressed gene profiles on the y-axis. Aligned heatmaps that 237 represent median expression with bins of cells are provided to annotate the one-238 dimensional UMAP protein and gene expression profiles. This approach allows easy 239 identification of cellular clusters that are similar by transcript, but separated by protein, 240 and vice versa ( Figure 3G ). One example for this is highlighted in Figure 3G (red box 241 and arrow), where cluster 2 (light green, containing TEMRA cells) is relatively 242 homogenous by transcript, but can be separated by CD56 protein expression, 243
probably marking some NKT cells. In turn, a fraction of cells between cluster 1 (dark 244 blue, effector memory CD8 + T cells) and 2 (green, TEMRA) shares the same protein 245 signature, but can be distinguished by GNLY and GZMH expression ( Fig. 3G , red box 246 and arrows). Varying degrees of concordance and ability to discriminate cellular 247 subsets from gene and protein expression profiles can be seen across this plot. 248
To determine if targeted transcriptomics is amenable for studying rare antigen-specific 249 T cell populations, we analyzed CD8 + T cells recognizing an EBV-epitope (Dunne et al., 250 2002) . Visualization on the UMAP plot revealed remarkable similarity of EBV-specific T 251 cells across all three donors ( Figure 3H ). As expected, most of the cells grouped within the effector memory CD8 + T cell cluster. However, relative to the EBV-nonspecific 253 memory T cell cluster the EBV-Tet + T cells showed a significant downregulation of the 254 effector molecule Granulysin, and an upregulation of YBX3, an RNA binding protein 255 whose function has not been defined in T cells, but has recently been shown to be a 256 critical regulator for the stability of specific mRNAs (Cooke et al., 2019) . 257
Overall, this data show that combining targeted transcriptomics and protein 258 phenotyping by sequencing is a valuable approach for studying T cell subsets and 259 could be used a resource-efficient tool for studying T cell responses in human disease. as was the case for CD69, a commonly utilized protein marker for early T cell activation 273 ( Figure 4B ). Of note, when we analyzed cytokine expression relative to the surface 274 protein expression of CD69, we observed that both IFNg as well as TNF transcript was primarily expressed in CD69-transcript positive, but CD69-protein negative cells, 276
suggesting that during very early stages of activation, CD69 protein might not be an 277
ideal marker for T cell activation. However, FOSB, part of the transcription factor AP-1, 278 was co-expressed with CD69-protein ( Figure 4B ), suggesting a close relationship of 279 FOSB and CD69 expression. 280
We focused our further analysis on CD8 + T cells only, though our data set also contains 281 information on NK cells. Projection on a UMAP plot showed 8 discernable clusters that 282 were selected manually. Protein expression patterns for CD45RA and CD45RO 283 highlight the naïve and the memory T cells within this plot ( Figure 4C ). A heatmap 284 visualization of the most highly expressed transcripts show that these clusters are 285 defined by differential expression of CCL3, CCL4, IFNG, TNF, and various granzymes 286 ( Figure 4D ). Overall, this analysis reveals considerable functional diversity within the 287 CD8 + T cell compartment that is detectable as early as one hour after stimulation. 288 289
Multi-omic analysis of the peripheral myeloid compartment reveals inflammatory 290 subsets not captured by surface protein phenotype 291
Next, we wanted to assess whether the targeted transcriptomics approach can also be 292 used for other immune populations that are not as well studied as T cells. During the 293 past decade it has become evident that the myeloid cell compartment is complex in 294 separation for CD14 and CD16 protein expression ( Figure 5B ). As expected, 301 visualization of the top differentially expressed genes ( Figure 5C ) as well as key surface 302 proteins ( Figure 5D ) mapped these clusters to CD123 + plasmacytoid dendritic cells 303 (pDCs), CD1c + conventional DCs (cDC2s), CD16 + monocytes and CD14 + monocytes. 304
We used One-SENSE to further explore the relationship between cluster 0 and 1, 305 revealing that these two populations were very similar in terms of surface protein 306 profile (CD14 + CD16 -), but separated by a specific set of transcripts encoding for pro-307 inflammatory cytokines and chemokines ( Figure 5E ). We confirmed that these 308 transcripts were part of differentially expressed genes as identified by MAST (Finak et 309 al., 2015) , with higher expression in cluster 1 of CXCL3 and CCL4 (also known as MIP-310 1b, a chemoattractant for natural killer cells) ( Figure 5E ). Thus, combining protein and 311 transcriptome data allowed us to observe multiple functional subsets within the 312 peripheral CD14 + myeloid population which were not apparent by surface marker 313 expression alone. In summary, this data highlights that targeted transcriptomics can be 314 used for exploratory studies of different immune compartments. The targeted transcriptomic approach that we describe here provides an alternative 332 platform that significantly lowers the number of reads required for sequencing 333 saturation of transcript compared to whole transcriptome (WTA) approaches, but still 334 provides valuable information on up to 499 immune-centric genes. Though this 335 approach sacrifices the unbiased nature of WTA measurements, many immunological 336 applications center on a set of critical immune effector molecules, such as cytokines, 337 chemokines or transcription factors. Also, a targeted approach avoids the significant 338 number of reads used by transcripts encoding ribosomal proteins which are often also 339 captured using a poly-A based whole transcriptome workflow. Furthermore, as shown here, in some cases, targeted analysis can permit higher sensitivity when it comes to 341 detecting relatively low abundance genes. Overall, in many experimental setups it 342 might be beneficial to combine both approaches: first utilize a WTA platform to identify 343 potentially unknown transcripts, and then use a targeted approach (which can be 344 tailored towards gene sets of interest) for profiling larger cell numbers or interrogating 345 cellular responses to specific stimuli. We provide proof-of-concept data that as early 346
as one hour after stimulation CD8 + T cells show heterogeneous patterns of chemokine 347
expression. Comprehensive chemokine and cytokine profiling of T cells after a very 348
short stimulus could be very valuable to gain additional insights into their function e.g. 349
in the context of cancer immunotherapy (Nagarsheth et al., 2017) . transcripts that are defining these cellular subsets (Stuart and Satija, 2019) . This issue 359 can be alleviated by measuring surface protein markers such as the splice variants 360 CD45RA and CD45RO, which have been well studied in the context of naïve and 361 memory T cells, or the IL-2 receptor alpha chain (CD25) and IL-7 receptor (CD127) for 362 the distinction of Tregs. In addition, parallel measurement of surface protein phenotypes allows to link novel cellular clusters (that are defined solely by transcript) 364 with a large body of literature that used to define cells by surface protein phenotype 365 only. Finally, the combined measurement approach can be useful to identify targets 366 with a significant disconnect between transcript and protein expression such as CD69, 367
probably indicative of active post-transcriptional modifications. 368
Of note, the development of novel technologies can sometimes outpace our ability to 369 validate platforms and reagents. Given that typical single cell sequencing experiments 370 require complex pre-processing steps and are often visualized using dimensionality 371 reduction techniques such as UMAP or t-SNE, there is a disconnect between the 372 actual raw data and the interpretation of final heatmaps. While this might be less of a 373 problem for transcript counts, antibody-based probes require careful validation. Here, 374
we have used high-dimensional cytometry, highlighting that not all reagents, even if the 375 same antibody clone is used, perform equally well in a multi-omic sequencing 376 experiment relative to conventional cytometry. Thus, with the more widespread 377 adoption of sequencing-based protein measurements, we argue that reagents need to 378 be carefully tested, preferably with parallel deposition in public databases. 379
Ultimately, to advance our understanding of biology the field relies on innovative 380 approaches to analyze and visualize complex high-dimensional data (Butler et al., this presents a challenge for combined protein-transcript data sets. To alleviate this 383 problem, we have adopted an analysis approach successfully used for high-384
dimensional cytometry data, one-dimensional soli expression by nonlinear stochastic 385 embedding (One-SENSE) (Cheng et al., 2016) . By visualizing the top-differentially expressed genes in one dimension relative to the measured protein phenotypes this 387 method allows to easily dissect cells that are similar in transcript, but different in 388 surface phenotype, and vice versa. This will be a useful tool for biologists to explore 389 future multi-omic data sets to extract biological meaning from these complex multi-390 dimensional data. 391
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Berger), and the Genomics Shared Resources Core of the FHCRC for sequencing. We (HVTN). Vials with cryopreserved cells were thawed at 37°C until a tiny ice crystal was 527 left in the tube, and then carefully diluted in 1mL of pre-warmed RPMI with 10% FBS 528 and transferred to a new tube. An additional 13 mL of pre-warmed RPMI with 10% 529 FBS were added drop by drop, followed by centrifugation for 5 minutes at 400g and 530 resuspension in 1 mL of RPMI. 531 532
Flow Cytometry and Cell sorting 533
For flow cytometric analysis good practices were followed as outlined in the guidelines 534 for use of flow cytometry (Cossarizza et al., 2017) . Following thawing, PBMCs were 535 incubated with Fc-blocking reagent (BioLegend Trustain FcX, #422302) and fixable UV 536
Blue Live/Dead reagent (ThermoFisher, #L34961) in PBS for 15 minutes at room 537 temperature. If required, cells were stained with an EBV-Tetramer reagent (peptide 538 YVLDHLIVV; Fred Hutch Immune Monitoring Core) diluted in FACS buffer (PBS with 539 2% FBS, Nucleus Biologics) for 30 minutes at room temperature, followed by two 540 washes. After this, cells were incubated for 20 minutes at room temperature with 541 antibody master mix freshly prepared in Brilliant staining buffer (BD Bioscience, # 542 563794), followed by two washes. All antibodies were titrated and used at optimal dilution, and staining procedures were performed in 96-well round-bottom plates. 544
Stained cells were fixed with 4% PFA for 20 minutes at room temperature, washed, 545 resuspended in FACS buffer and stored at 4°C in the dark until acquisition. 546
All samples were acquired using a FACSymphony A5 (BD Biosciences), equipped with 547 30 detectors and 355nm, 405nm, 488nm, 532nm and 628nm lasers and FACSDiva (BD 548 Biosciences). Detector gains were optimized using a modified voltage titration 549 approach (Perfetto et al., 2012) and standardized from day to day using 6-peak Ultra 550
Rainbow Beads (Spherotec, # URCP-38-2K). Single-stained controls were prepared 551 with every experiment using antibody capture beads diluted in FACS buffer (BD 552
Biosciences anti-mouse, #552843 and anti-rat, #552844). After acquisition, data was 553 exported in FCS 3.1 format and analyzed using FlowJo (version 10.5.x, BD 554 Biosciences). Doublets were excluded by FSC-A vs FSC-H gating. For some of the 555 plots, the number of acquired cells was down-sampled using the appropriate FlowJo 556 plugin to match the number of cells analyzed by AbSeq. 557
All cell sorting was performed on a FACSAria III (BD Biosciences), equipped with 20 558 detectors and 405nm, 488nm, 532nm and 628nm lasers. For all sorts, an 85 µm nozzle 559 operated at 45 psi sheath pressure was used. Cells were sorted into chilled Eppendorf 560 tubes containing 500 µL of RPMI, washed once in PBS and immediately used for 561 subsequent processing. 562 563
Targeted Transcriptome and protein single-cell library preparation and 564
Sequencing 565
